IPO Guru

IPO Listed — 21 Jan 2026

Listing Price: ₹317 (-12.19% vs ₹361)

View GMP History →
Amagi Media Labs

Amagi Media Labs IPO Review

Amagi Media Labs IPO has been reviewed by 14 analysts, and the overall consensus is Apply — carrying a score of 73. Out of the 14 analysts who have covered this IPO, 7 recommend subscribing while 7 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹343 to 361 per share , with a minimum application size of 41 shares (minimum investment of approximately ₹14,063 at the upper band) . Subscription ran from 13 Jan 2026 to 16 Jan 2026. As of now, the grey market premium (GMP) for Amagi Media Labs IPO is quoting at ₹1, which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Amagi Media Labs provides cloud technology for broadcast and streaming media. Revenue grew steadily from ₹724.72 crore in FY23 to ₹1,223.31 crore in FY25, with EBITDA turning positive at ₹23.49 crore after two years of heavy losses. Seven of the seventeen analysts said subscribe, three stayed neutral and two said avoid.

Listing Gains

With minimal profit, the notes value the issue on revenue, at about 5 to 7 times sales, or an extreme 603 times on annualised FY26 earnings by one calculation. Analysts describe the pricing as very premium. The split between subscribe, neutral and avoid ratings pointed to a muted listing.

Short Term Strategy

The inflection has only just happened. EBITDA moved from losses of ₹140.34 crore and ₹155.53 crore in FY23 and FY24 to a positive ₹23.49 crore in FY25. Analysts repeatedly note the history of losses and negative cash flows, and fresh money funds technology and cloud infrastructure spending.

Long Term Strategy

The positive notes recommend a medium to long-term horizon, resting on the structural shift of broadcast to cloud and Amagi's position in that transition. The caution across the coverage is that financial performance remains sensitive, so the long-term case depends on the recent profitability proving durable rather than temporary.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Apply
73 / 100

Recommend Subscribe

Based on 14 analyst reviews

7 / 14

Higher consensus indicates broader analyst agreement.

Analyst Review

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Amagi Media Labs IPO?

Based on analyst coverage tracked on this page, the overall verdict for Amagi Media Labs IPO is Apply. Out of 14 analysts who have reviewed this IPO, 7 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 73 mean for Amagi Media Labs IPO?

The score of 73 is an aggregate of all analyst ratings tracked for Amagi Media Labs IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Amagi Media Labs IPO?

Amagi Media Labs IPO listed on January 21, 2026 at ₹317 , against the issue price of ₹361 — a loss of -12.19% (₹44 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Amagi Media Labs IPO?

Amagi Media Labs IPO was priced at ₹343 to 361 per share. The minimum lot size is 41 shares, making the minimum investment approximately ₹14,063 at the upper end of the price band. Subscription ran from 13 Jan 2026 to 16 Jan 2026.

Explore Amagi Media Labs IPO Further

Track every stage of this IPO:

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.